Enzymatic degradation of azaserine.
作者信息
JACQUEZ J A, SHERMAN J H
出版信息
Cancer Res. 1962 Jan;22:56-61.
PMID:14450824
Abstract
摘要
相似文献
1
Enzymatic degradation of azaserine.
Cancer Res. 1962 Jan;22:56-61.
2
Effect of azaserine (o-diazoacetyl-L-serine) on the pyridine nucleotide levels of mouse liver.
Nature. 1959 Jun 13;183(4676):1674-5. doi: 10.1038/1831674b0.
3
Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
Am J Physiol. 1958 Oct;195(1):244-50. doi: 10.1152/ajplegacy.1958.195.1.244.
4
The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
Tex Rep Biol Med. 1957;15(1):148-53.
5
Observations on the action of azaserine in mammalian tissues.
Cancer Res. 1957 Jul;17(6):609-12.
6
Purine metabolism in bacteria. IV. L-azaserine as an inhibitor.
J Bacteriol. 1956 Dec;72(6):858-64. doi: 10.1128/jb.72.6.858-864.1956.
7
Mutagenic effect of azaserine in relation to azaserine resistance in Escherichia coli.
Science. 1959 Mar 27;129(3352):839-40. doi: 10.1126/science.129.3352.839.
8
Azaserine: pathological and pharmacological studies.
Cancer. 1957 Sep-Oct;10(5):889-901. doi: 10.1002/1097-0142(195709/10)10:5<889::aid-cncr2820100506>3.0.co;2-t.
9
Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor.
Cancer Res. 1962 Jan;22:27-37.
10
Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes.
J Natl Cancer Inst. 1958 Nov;21(5):973-84.
Zotero 插件